-transparent.png){kind=logo}
The substance under study was employed in 9 patients with a far-advanced lesion. Dosage of 7.5 mg/m2 of the body surface failed to render any effect, whereas 15 mg/m2 induced partial regression in 2 patients and stabilization of the process in another 2 patients. Some toxic phenomena were noted on the part of the digestive tract.
Related Publications
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
December 1975,
Biochimica et biophysica acta,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
March 1991,
FEMS microbiology letters,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
October 1981,
Tumori,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
July 1971,
Strahlentherapie,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
December 1989,
European journal of cancer & clinical oncology,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
October 1973,
Journal of the National Cancer Institute,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
August 1975,
Biochimica et biophysica acta,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
October 1978,
Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
October 1983,
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
J Fiserová, and
O Dostálová, and
J Drobnik, and
J Faistavr, and
F Holik
January 1878,
British medical journal,
